Premenstrual Syndromes : PMS and PMDD - Rutuja :: The site ...

80 THE PREMENSTRUAL SYNDROMES
110. Morales M, Battenberg E, de Lecea L et al. The type 3 serotonin
receptor is expressed in a subpopulation of GABAergic neurons
in the rat neocortex and hippocampus. Brain Res 1996;
731:199–202.
111. Willins DL, Deutch AY, Roth BL. Serotonin 5-HT2A receptors
are expressed on pyramidal cells and interneurons in the rat
cortex. Synapse 1997; 27:79–82.
112. Gellman RL, Aghajanian GK. Pyramidal cells in piriform cortex
receive a convergence of inputs from monoamine activated
GABAergic interneurons. Brain Res 1993; 600:63–73.
113. Soderpalm B, Andersson G, Enerback C et al. In vivo administration
of the 5-HT1A receptor agonist 8-OH-DPAT interferes
with brain GABA(A)/benzodiazepine receptor complexes.
Neuropharmacology 1997; 36:1071–7.
114. Sibille E, Pavlides C, Benke D et al. Genetic inactivation of
the serotonin(1A) receptor in mice results in downregulation
of major GABA(A) receptor alpha subunits, reduction of
GABA(A) receptor binding, and benzodiazepine-resistant
anxiety. J Neurosci 2000; 20:2758–65.
115. Vargyas J, Lobo R, Mishell DB. Brain opioid activity in the premenstrual
syndrome. Fertil Steril 1984; 42:324.
116. Chuong CJ, Coulam CB, Bergstralh EJ et al. Clinical trial of
naltrexone in premenstrual syndrome. Obstet Gynecol 1988;
72(3 Pt 1):332–6.
117. Krieger DT, Liotta AS, Brownstein MJ et al. ACTH, betalipotropin,
and related peptides in brain, pituitary, and blood.
Recent Prog Horm Res 1980; 36:277–344.
118. Facchinetti F, Petraglia F, Genazzani AR. Localization and
expression of the three opioid systems. Semin Reprod Endocrinol
1987; 5:103.
119. Eipper BA, Mains RE. Structure and biosynthesis of pro-adrenocorticotropin/endorphin
and related peptides. Endocr Rev 1980;
1:1–27.
120. Evans CJ, Erdelyi E, Weber E et al. Identification of proopiomelanocortin-derived
peptides in the human adrenal
medulla. Science 1983; 221:957–60.
121. Yen SS, Quigley ME, Reid RL et al. Neuroendocrinology of
opioid peptides and their role in the control of gonadotropin and
prolactin secretion. Am J Obstet Gynecol 1985; 152:485–93.
122. Miller RJ. Multiple opiate receptors for multiple opioid peptides.
Med Biol 1982; 60:1–6.
123. Grossman A. Brain opiates and neuroendocrine function. Clin
Endocrinol Metab 1983; 12:725–46.
124. Seifer DB, Collins RL. Current concepts of beta-endorphin physiology
in female reproductive dysfunction. Fertil Steril 1990;
54:757–71.
125. Chang KJ, Cooper BR, Hazum E et al. Multiple opiate receptors:
different regional distribution in the brain and differential
binding of opiates and opioid peptides. Mol Pharmacol 1979;
16:91–104.
126. Wilkes MM, Watkins WB, Stewart RD et al. Localization and
quantitation of beta-endorphin in human brain and pituitary.
Neuroendocrinology 1980; 30:113–21.
127. Watkins WB, Yen SS, Moore RY. Presence of beta-endorphin-like
immunoreactivity in the anterior pituitary gland of rat and
man and evidence for the differential localization with ACTH.
Cell Tissue Res 1981; 215:577–89.
128. Silverman AJ, Antunes JL, Abrams GM et al. The luteinizing
hormone-releasing hormone pathways in rhesus (Macaca
mulatta) and pigtailed (Macaca nemestrina) monkeys: new
observations on thick, unembedded sections. J Comp Neurol
1982; 221:309–17.
129. Wardlaw SL, Wehrenberg WB, Ferin M et al. High levels of betaendorphin
in hypophyseal portal blood. Endocrinology 1980;
106:1323–6.
130. Ferin M, Wehrenberg WB, Lam NY et al. Effects and site of
action of morphine on gonadotropin secretion in the female
rhesus monkey. Endocrinology 1982; 111:1652–6.
131. Rasmussen DD, Liu JH, Wolf PL et al. Endogenous opioid regulation
of gonadotropin-releasing hormone release from the
human fetal hypothalamus in vitro. J Clin Endocrinol Metab
1983; 57:881–4.
132. Blank MS, Roberts DL. Antagonist of gonadotropin-releasing
hormone blocks naloxone-induced elevations in serum luteinizing
hormone. Neuroendocrinology 1982; 35:309–12.
133. Wehrenberg WB, Wardlaw SL, Frantz AG et al. Beta-Endorphin
in hypophyseal portal blood: variations throughout the menstrual
cycle. Endocrinology 1982; 111:879–81.
134. Wardlaw SL, Wehrenberg WB, Ferin M et al. Effect of sex
steroids on beta-endorphin in hypophyseal portal blood. J Clin
Endocrinol Metab 1982; 55:877–81.
135. Reid RL, Hoff JD, Yen SS et al. Effects of exogenous beta
h-endorphin on pituitary hormone secretion and its disappearance
rate in normal human subjects. J Clin Endocrinol Metab
1981; 52:1179–84.
136. Quigley ME, Yen SS. The role of endogenous opiates in LH
secretion during the menstrual cycle. J Clin Endocrinol Metab
1980; 51:179–81.
137. Ropert JF, Quigley ME, Yen SS. Endogenous opiates modulate
pulsatile luteinizing hormone release in humans. J Clin Endocrinol
Metab 1981; 52:583–5.
138. Blankstein J, Reyes FI, Winter JS et al. Endorphins and the regulations
of the human menstrual cycle. Clin Endocrinol (Oxf)
1981; 14:287–94.
139. Shoupe D, Montz FJ, Lobo RA. The effects of estrogen and
progestin on endogenous opioid activity in oophorectomized
women. J Clin Endocrinol Metab 1985; 60:178–83.
140. Reid RL, Yen SS. Premenstrual syndrome. Am J Obstet Gynecol
1981; 139:85–104.
141. Chuong CJ, Coulam CB, Kao PC et al. Neuropeptide levels in
premenstrual syndrome. Fertil Steril 1985; 44:760–5.
142. Chuong CJ, Hsi BP. Effect of naloxone on luteinizing hormone
secretion in premenstrual syndrome. Fertil Steril 1994;
61(6):1039–44.
143. Rapkin AJ, Shoupe D, Reading A et al. Decreased central opioid
activity in premenstrual syndrome: luteinizing hormone
response to naloxone. J Soc Gynecol Investig 1996; 3:93–8.
144. Facchinetti F, Martignoni E, Petraglia F et al. Premenstrual fall
of plasma beta-endorphin in patients with premenstrual syndrome.
Fertil Steril 1987; 47:570–3.
145. Mendelson JH, Ellingboe J, Keuhnle JC et al. Effects of naltrexone
on mood and neuroendocrine function in normal adult
males. Psychoneuroendocrinology 1978; 3:231–6.
146. Cohen MR, Cohen RM, Pickar D et al. Behavioural effects after
high dose naloxone administration to normal volunteers. Lancet
1981; 2:1110.
147. Van Loon GR, De Souza EB. Effects of beta-endorphin on brain
serotonin metabolism. Life Sci 1978; 23:971–8.
148. Brase DA. Roles of serotonin and gamma-aminobutyric acid in
opioid effects. Adv Biochem Psychopharmacol 1979; 20:409–28.
149. Foresta C, Scanelli G, Tramarin A et al. Serotonin but not
dopamine is involved in the naloxone-induced luteinizing
hormone release in man. Fertil Steril 1985; 43:447–50.
150. Vugt DA, Meites J. Influence of endogenous opiates on anterior
pituitary function. Fed Proc 1980; 39:2533–8.
151. Haubrich DR, Blake DE. Modification of serotonin metabolism
in rat brain after acute or chronic administration of morphine.
Biochem Pharmacol 1973; 22:2753–9.
152. Mellon SH, Griffin LD. Neurosteroids: biochemistry and clinical
significance. Trends Endocrinol Met 2002; 13(1):35–43.